Aug 11, 2011 · Hib Disease Increasing Among Adults. Haemophilus influenzae type b (Hib) disease is a bacterial illness that can cause pneumonia, meningitis, and blood infection and can sometimes be fatal. Spread by direct contact or via droplets from coughing or sneezing, Hib disease has decreased dramatically in children due to the advent of a Hib vaccine in 1992.Author: Denise Mann. Jun 14, 2012 · Haemophilus influenzae is present as a commensal organism in the nasopharynx of most healthy adults from where it can spread to cause both systemic and respiratory tract infection. This bacterium is divided into typeable forms (such as type b) or nontypeable forms based on the presence or absence of a tough polysaccharide capsule.Cited by: 67.
Haemophilus influenzae type b (Hib) Hib infections used to be a serious health problem in the UK, but the routine immunisation against Hib, given to infants since 1992, means these infections are now rare. Of the small number of cases that do occur nowadays, most affect adults with long-term (chronic) underlying medical conditions, rather than young children. H. influenzae Type B Immunization. IM injection indicated for routine immunization in children aged 2 months to 15 months and up to 5 years for catch up vaccination. Primary series (6 weeks to 12 months): 2 or 3 doses. Booster: 3rd or 4th dose between 12-15 months.
Haemophilus influenzae is a Gram-negative coccobacillus that can cause serious invasive disease in children and adults. The most prevalent strain is type b (Hib).Author: Public Health England. Diseases. Naturally acquired disease caused by H. influenzae seems to occur in humans only. In infants and young children, H. influenzae type b (Hib) causes bacteremia, pneumonia, epiglottitis and acute bacterial meningitis. On occasion, it causes cellulitis, osteomyelitis, and infectious arthritis.
Ask the Experts. Secondary cases of Hib disease (illness occurring within 60 days of contact with a patient) occur but are rare. Secondary attack rates are higher among household contacts younger than 48 months (2.1%), especially those younger than 12 months (6%) and younger than 24 months (3%).